Results 1 to 10 of about 1,298,129 (315)

China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasm (2022 edition) [PDF]

open access: yesZhongguo aizheng zazhi, 2022
Neuroendocrine neoplasm (NEN) is a kind of rare tumor that originated from peptidergic neurons and neuroendocrine cells, which has neuroendocrine differentiation and expresses neuroendocrine markers.
of Neuroendocrine Neoplasm of China Anti-Cancer Association Society
doaj   +2 more sources

Clinical significance of diagnostic laparoscopy on precision staging in advanced gastric cancer [PDF]

open access: yesWaike lilun yu shijian, 2022
Gastric cancer is the leading cause of cancer-related deaths in human. More than 70% patients present with advanced gastric cancer or with metastasis in clinic.
NIE Mingming, ZHU Zhenggang
doaj   +1 more source

Effect of Osimertinib in Combination With Chemotherapy and Bevacizumab for Untreated Epidermal Growth Factor Receptor–Mutated Advanced Non-Small-Cell Lung Cancer: Case Report

open access: yesFrontiers in Pharmacology, 2021
Introduction: Osimertinib is an oral, third-generation, irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that selectively inhibits both EGFR-TKI–sensitizing and EGFR T790M resistance mutations.
Haifeng Qin   +5 more
doaj   +1 more source

MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms

open access: yesScientific Reports, 2023
MALAT1 long non-coding RNA has oncogenic roles but has been poorly studied in indolent B-cell neoplasms. Here, MALAT1 expression was analyzed using RNA-seq, microarrays or qRT-PCR in primary samples from clinico-biological subtypes of chronic lymphocytic
Elena María Fernández-Garnacho   +17 more
doaj   +1 more source

A Review of Scheduling Strategies for Radiotherapy and Immune Checkpoint Inhibition in Locally Advanced Rectal Cancer [PDF]

open access: yesJournal of Immunotherapy and Precision Oncology, 2023
Colorectal cancer (CRC) is the third most common malignancy across the globe and, despite advances in treatment strategies, survival rates remain low. Rectal cancer (RC) accounts for most of these cases, and traditional management strategies for advanced
Lydia Melissourgou-Syka   +5 more
doaj   +1 more source

Epidemiological Study on the Causes of Mortality Among Children Aged 5-14 Years in the Northeast of Iran in 2013- 2019: A Descriptive Study [PDF]

open access: yesInternational Journal of Epidemiologic Research, 2022
Background and aims: To identify the pattern and causes of death and to deal with them are among the most appropriate strategies to increase human life expectancy.
Mohammadtaghi Shakeri   +4 more
doaj   +1 more source

Methotrexate-induced toxicities in children with malignancy: a systematic review and meta-analysis [PDF]

open access: yesWorld Cancer Research Journal, 2021
Objective: Methotrexate (MTX) is an anticancer and anti-inflammatory drug widely used to treat various diseases. Some patients are more susceptible to toxicity, some show resistance to chemotherapy. The most conducted studies have investigated the effect
S. Gharibi   +3 more
doaj   +1 more source

Solid Pseudopapillary Neoplasm of the Pancreas As a Rare Cause of Relapsing Acute Pancreatitis: A Case Report [PDF]

open access: yes, 2020
Solid pseudopapillary neoplasm of the pancreas is a rare tumor with low malignant potential. Although they are diagnosed incidentally, acute or relapsing pancreatitis in association with this tumor are reported rarely.
Kemal DOLAY   +3 more
core   +1 more source

pediatric parotid neoplasm [PDF]

open access: yes, 2023
pediatric parotid ...
Abdalwahab Raafat (14467431)
core   +1 more source

Robotic enucleation of a solid pseudopapillary neoplasm in a 9-year-old girl [PDF]

open access: yes, 2020
Objective: Here we reported the case of a 9-year-old girl with no relevant past medical or surgical history. Solid pseudopapillary neoplasms (SPN) is a rare pancreatic tumor, which is often observed in females in their second or third decades, but it can
E. Santonocito   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy